Understanding the Long-Term Side Effects of Vraylar Medication

When considering the use of Vraylar, a prescription medication for the treatment of bipolar disorder and schizophrenia, it is important to understand not only the immediate side effects but also the potential long-term consequences. The Mayo Clinic highlights that while some side effects may resolve with time, others could persist and require medical attention. Let's delve into the common and less common long-term side effects associated with the use of Vraylar.

Common Side Effects that May Be Transient

Many of the side effects associated with Vraylar are relatively common and may diminish over time as your body adjusts to the medication. If you experience any of the following symptoms, it may be beneficial to report them to your healthcare provider but often they are not indicative of a severe underlying issue.

Body aches or pain Cramps Difficulty in moving Ear congestion Heavy bleeding Loss of voice Muscle aches Muscle pain or stiffness Nasal congestion Pain Pain in joints Sneezing Sore throat Stuffy or runny nose

More Severe and Less Common Long-Term Side Effects

It is crucial to be aware of the more severe and potentially long-lasting side effects associated with the prolonged use of Vraylar. These include:

HUS / TTP or Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura

These rare but serious conditions involve the destruction of red blood cells and a reduction in platelet counts, which can impair blood clotting. They are relatively uncommon side effects, but if left untreated, they can be life-threatening. It is essential to monitor for any signs of these conditions and report any unusual symptoms to your healthcare provider immediately.

Other long-term health risks associated with the use of antipsychotics, including Vraylar, can include:

Tardive Dyskinesia

This condition is a movement disorder that can develop after prolonged use of antipsychotics. It is characterized by involuntary and often repetitive movements of the face, body, and limbs. Tardive dyskinesia can be challenging to manage and may persist even after the medication is discontinued.

Increased Risk of Diabetes and Weight Gain

Vraylar, like other second-generation antipsychotics, can increase the risk of developing diabetes and weight gain. Regular blood work can help monitor for these conditions, and lifestyle modifications may be recommended to mitigate these risks. Your healthcare provider may suggest routine assessments for cholesterol and triglycerides to ensure these levels do not become elevated, which could further increase the risk of cardiovascular issues.

Conclusion

The use of Vraylar can offer significant benefits for managing symptoms of bipolar disorder and schizophrenia, but it is essential to be aware of the potential long-term side effects. Regular communication with your healthcare provider and proactive management of lifestyle and health metrics can help minimize the impact of these side effects and improve overall quality of life.